RetinalGenix Technologies Inc RTGN
Trading Information
- Previous Close Price
- $4.00
- Day Range
- $3.99–4.00
- 52-Week Range
- $3.20–4.01
- Bid/Ask
- $1.50 / $3.99
- Shares Outstanding
- 18.84M
- Market Cap
- $74.83M
- Volume/Avg
- 684 / 738
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
RetinalGenix Technologies Inc is an ophthalmic research and development company focused on developing technologies to screen, monitor, diagnose, and treat ocular, optical, and sight-threatening disorders, Its mission is to prevent vision loss and blindness due to diabetic retinopathy and maculopathy through early detection from the use of two devices: Retinal Imaging Screening Device a portable, retinal imaging system providing a wide field of view without requiring pupil dilation; and RetinalCamTM, being designed as a high-resolution home monitoring retinal imaging device and physician alert system offering real-time communication with physicians available.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- —
- Total Number of Employees
- 0
- Website
- https://www.retinalgenix.com
Valuation
|
Metric
|
RTGN
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
RTGN
|
|---|---|
Quick Ratio | 0.01 |
Current Ratio | 0.01 |
Interest Coverage | −287.61 |
Quick Ratio
RTGN
Profitability
|
Metric
|
RTGN
|
|---|---|
Return on Assets (Normalized) | −8,707.41% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
RTGN
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|v>b%%X& | LOCK|bLz%B | $174B | |||
| Medtronic PLC
MDT
| LOCK|>kR?&m | LOCK|@y@?R | $119B | |||
| Stryker Corp
SYK
| LOCK|Kcd$j^g% | LOCK|z^g | $114B | |||
| Boston Scientific Corp
BSX
| LOCK|ldfhQ< | LOCK|&#>y | $65B | |||
| Edwards Lifesciences Corp
EW
| LOCK|B?&HK!m | LOCK|#&mh | $51B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|HXw^&#< | LOCK|@$ | $31B | |||
| DexCom Inc
DXCM
| LOCK|F#>?PYk! | LOCK|Xt#w | $30B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|KjC | LOCK|cN | $26B | |||
| Steris PLC
STE
| LOCK|^>N$&& | LOCK|Lc^^ | $22B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|<H^X?gnF | LOCK|^! | $18B |
United States